MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$2.70 USD
+0.02 (0.75%)
Updated Apr 26, 2024 09:45 AM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for MAIA Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -19.77 | -15.77 | -12.58 | NA | NA |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.60 | NA | NA |
Net Change from Assets/Liabilities | 3.09 | 0.79 | 1.13 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 3.62 | 3.32 | 6.73 | NA | NA |
Net Cash From Operating Activities | -13.07 | -11.66 | -4.12 | NA | NA |
Property & Equipment | 0.00 | 0.00 | 0.00 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.42 | 14.44 | 6.28 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 7.43 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -2.15 | -2.41 | 0.32 | NA | NA |
Net Cash from Financing Activities | 9.27 | 12.04 | 14.03 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -3.80 | 0.38 | 9.91 | NA | NA |
Cash at Beginning of Period | 10.95 | 10.57 | 0.66 | NA | NA |
Cash at End of Period | 7.15 | 10.95 | 10.57 | NA | NA |
Diluted Net EPS | -1.49 | -1.75 | -2.37 | NA | NA |
Fiscal Year End for MAIA Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -19.77 | -13.52 | -8.64 | -4.12 |
Depreciation/Amortization & Depletion | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | NA | 3.09 | 2.17 | 1.20 | 0.08 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.62 | 2.27 | 1.52 | 0.68 |
Net Cash From Operating Activities | NA | -13.07 | -9.08 | -5.92 | -3.36 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 11.42 | 5.75 | 5.75 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -2.15 | -1.51 | -1.63 | 0.00 |
Net Cash from Financing Activities | NA | 9.27 | 4.25 | 4.12 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | -0.01 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -3.80 | -4.85 | -1.80 | -3.36 |
Cash at Beginning of Period | NA | 10.95 | 10.95 | 10.95 | 10.95 |
Cash at End of Period | NA | 7.15 | 6.10 | 9.15 | 7.59 |
Diluted Net EPS | NA | -0.40 | -0.36 | -0.35 | -0.38 |